Cure8 research brief
Why This Matters
This study shows a mechanism by which IL-10 protects gut epithelial mitochondria and barrier function during exposure to an IBD-associated E. coli strain, which could be relevant to understanding pathways that maintain remission or limit flares in IBD.
Who Should Pay Attention
Researchers (IBD, mitochondrial biology), translational clinicians, and scientists developing epithelial-protective strategies for IBD.
Study Snapshot
What To Know
This lab-based study reports that the anti-inflammatory cytokine IL-10 preserves mitochondrial function and epithelial barrier integrity in human colon epithelial cells and organoids challenged with the IBD-associated bacterium adherent-invasive E. coli (AIEC, strain LF82).
The authors link protection to ERK-dependent phosphorylation of STAT3 at serine 727, which supports mitochondrial respiration, membrane potential, and limits permeability transition pore opening and fragmentation.
The work uses in vitro cell lines, human colonic organoids, genetic manipulations of STAT3, and pharmacologic inhibitors to map the signaling pathway; it contrasts IL-10’s effects with IL-22 and highlights a mitochondrial role for STAT3S727.
Keep In Mind
Findings come from in vitro human cell lines and colonic organoids with molecular and pharmacologic experiments; they are mechanistic and not clinical results.
Source Details
Review the original publication for the complete reporting, methods, and context.
Conflict statement: The authors have declared that no conflict of interest exists.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.